Kamada (KMDA) Gross Margin (2012 - 2026)
Kamada (KMDA) posted quarterly Gross Margin of 42.25% for Q1 2026, down 488.0% year-on-year from 10.89% in Q1 2025, and up 11.27% on a QoQ basis from 37.98% in Q4 2025.
Kamada (KMDA) Gross Margin (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Gross Margin for 15 consecutive years, with 42.25% the latest figure, recorded in Q1 2026.
- Quarterly Gross Margin fell 488.0% year-over-year to 42.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 42.29% (down 233.0% YoY) and the FY2025 annual result came in at 42.34%, down 113.0% from the prior year.
- Gross Margin improved to 42.25% in Q1 2026 per KMDA's latest filing, from 37.98% in the prior quarter.
- Over the last five years, Gross Margin for KMDA reached as high as 47.14% in Q1 2025 and fell as low as 30.69% in Q2 2022.
- A 5-year average of 40.35% and a median of 40.23% in 2022 frame the typical range for Gross Margin.
- The largest YoY upside for Gross Margin was 1507 bps in 2022 against a maximum downside of 674 bps in 2022.
- Year by year, Gross Margin stood at 33.65% in 2022, then climbed by 18 bps to 39.56% in 2023, then gained by 10 bps to 43.66% in 2024, then dropped by 13 bps to 37.98% in 2025, then advanced by 11 bps to 42.25% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 42.25%, 37.98%, and 42.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 42.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.25% |
| Dec 31, 2025 | 37.98% |
| Sep 30, 2025 | 42.04% |
| Jun 30, 2025 | 42.30% |
| Mar 31, 2025 | 47.14% |
| Dec 31, 2024 | 43.66% |
| Sep 30, 2024 | 41.29% |
| Jun 30, 2024 | 44.62% |
| Mar 31, 2024 | 44.39% |
| Dec 31, 2023 | 39.56% |
| Sep 30, 2023 | 39.02% |
| Jun 30, 2023 | 38.55% |
| Mar 31, 2023 | 38.55% |
| Dec 31, 2022 | 33.65% |
| Sep 30, 2022 | 39.95% |
| Jun 30, 2022 | 30.69% |
| Mar 31, 2022 | 40.23% |
| Dec 31, 2021 | 20.96% |
| Sep 30, 2021 | 24.88% |
| Jun 30, 2021 | 37.43% |